SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D - General statement of acquisition of beneficial ownership:
SEC Accession No. 0001193125-23-030224
Filing Date
2023-02-09
Accepted
2023-02-09 16:49:01
Documents
2
Group Members
BLACKSTONE CLARUS GP L.L.C.BLACKSTONE CLARUS GP L.P.BLACKSTONE GROUP MANAGEMENT L.L.C.BLACKSTONE HOLDINGS I L.P.BLACKSTONE INC.CLARUS IV GALERA ROYALTY AIV, L.P.CLARUS IV GP, L.P.CLARUS IV-A, L.P.CLARUS IV-B, L.P.CLARUS IV-C, L.P.CLARUS IV-D, L.P.STEPHEN

Document Format Files

Seq Description Document Type Size
1 SC 13D d452868dsc13d.htm SC 13D 245780
2 EX-99.A d452868dex99a.htm EX-99.A 21420
  Complete submission text file 0001193125-23-030224.txt   269277
Mailing Address C/O BLACKSTONE INC. 345 PARK AVENUE NEW YORK NY 10154
Business Address C/O BLACKSTONE INC. 345 PARK AVENUE NEW YORK NY 10154 2125835000
Blackstone Holdings I/II GP L.L.C. (Filed by) CIK: 0001464695 (see all company filings)

IRS No.: 260238303 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D

Mailing Address 2 WEST LIBERTY BLVD #100 MALVERN PA 19355
Business Address 2 WEST LIBERTY BLVD #100 MALVERN PA 19355 610-725-1500
Galera Therapeutics, Inc. (Subject) CIK: 0001563577 (see all company filings)

IRS No.: 461454898 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D | Act: 34 | File No.: 005-91201 | Film No.: 23606989
SIC: 2834 Pharmaceutical Preparations